3Bar Biologics

Based in Columbus, Ohio, 3Bar Biologics is an agricultural biotechnology company that develops sustainable microbial inoculants and proprietary in-package fermentation technology to improve crop yields. The organization provides a business-to-business delivery system enabling farmers and agricultural manufacturers to activate beneficial microbes on-site, ensuring maximum viability at the time of application. Operating with fewer than 50 employees, the enterprise generates approximately $5.5 million in annual revenue and has secured over $3 million in total early-stage funding. This capitalization includes a $2 million oversubscribed financing round in 2020 and a $250,000 investment following the 2021 AgSharks competition. The startup operates as a commercial spin-out from The Ohio State University and is backed by institutional investors including Rev1 Ventures, Maumee Ventures, and S2G Ventures. 3Bar Biologics was founded in 2013 by Bruce Caldwell.